1. Introduction {#sec1}
===============

*Candida parapsilosis* has emerged as an opportunistic fungal pathogen over the last two decades especially in debilitated patients and low birth weight neonates.[@bib1] Though typically a commensal of human skin, its capacity to form biofilms on catheters and implants accounts for its increased incidence within the nosocomial setting.[@bib2] *Candida parapsilosis* is a well-known cause of delayed-onset postoperative endophthalmitis with at least 3 epidemics in the mid-1980s due to contaminated irrigating solutions used intraoperatively.[@bib3], [@bib4], [@bib5] It has also been described as the causative organism for suppurative fungal keratitis and crystalline keratopathy after corneal transplantation,[@bib6]^,^[@bib7] laser in situ keratomileusis (LASIK),[@bib8] insertion of intracorneal ring segments,[@bib9] treatment of epithelial ingrowth post-LASIK,[@bib10] trauma with vegetable matter,[@bib11] and Boston type 1 keratoprosthesis implantation.[@bib12]

Herein, a case of *Candida parapsilosis* cornea tunnel infection with late-onset endophthalmitis is reported after cataract surgery via phacoemulsification and all similar cases in the literature of fungal tunnel infections post-cataract surgery are reviewed.

2. Findings {#sec2}
===========

A 62-year old female self-referred to the Bascom Palmer Eye Institute (BPEI) Emergency Department for further management of chronic postoperative anterior uveitis in her left eye. The patient had history of uncomplicated cataract surgery with insertion of a posterior chamber intraocular lens (IOL) 7 months prior to presentation. She had been treated with topical difluprednate 0.05% and bromfenac 0.07% eye drops for recurrent inflammation in the anterior chamber. At least 3 attempts were made by her surgeon and an outside retina specialist to taper her anti-inflammatory regimen without success. Past medical history did not reveal other predisposing factors or increased risks for developing a Candida infection. An extensive uveitis work-up, which included a complete blood count, sedimentation rate, Quantiferon gold test, chest X-ray, rapid plasma reagin (RPR), fluorescent treponemal antibody (FTA-ABS), angiotensin converting enzyme, serum lysozyme, anti-nuclear antibody (ANA), toxoplasmosis IgM and IgG antibodies, HLA B27 antigen, HLA B51 antigen and Lyme titers, was performed and was negative.

Two weeks prior to presentation to us she experienced increased redness and light sensitivity. Her outside retina specialist noted new keratic precipitates, 1 + cell in the anterior chamber, a new infiltrate along the clear cornea cataract incision tract and new focal deposits on the posterior surface of the IOL and inside the capsular bag. Given the concern for chronic postoperative endophthalmitis, an anterior chamber culture was sent by her outside physician and vancomycin and moxifloxacin were injected intracamerally and ceftazidime was injected intravitreally. On postoperative day 3, the patient experienced recurrence of the anterior chamber inflammation and reported to BPEI for further management.

Upon presentation to us, her left eye had mild perilimbal injection, a noticeable infiltrate along the clear cornea cataract tunnel temporally, a small hypopyon and endothelial plaque inferiorly, and white fluffy-appearing deposits between the IOL and the capsular bag temporally ([Fig. 1](#fig1){ref-type="fig"}). There was no vitritis and her vision was 20/50. At this time, the anterior chamber cultures from the outside medical center came back positive for *Candida*. A repeat anterior chamber washout and cultures, scraping of the endothelial plaque and injections of intracameral and intravitreal amphotericin B (0.2 mL of 5 mcg/0.1 mL) were performed. She was also started on hourly topical amphotericin B 0.5 mg/mL drops and topical steroids were stopped. Cultures showed *C. parapsilosis* and pathology of the endothelial plaque that was removed revealed fungal elements.Fig. 1Slit lamp photograph at presentation (7 months after cataract surgery in the patient\'s left eye). 1A - A stromal infiltrate along the clear cornea cataract tunnel is present temporally, while a 1 mm hypopyon and endothelial plaque are visible inferiorly. 1B - White fluffy-appearing deposits between the IOL and the capsular bag are seen temporally. There was no evidence of vitritis and the patient\'s visual acuity was 20/50.Fig. 1

Despite a repeat intracameral amphotericin B injection 3 days after the anterior chamber washout, the hypopyon, capsular/IOL deposits and intrastromal wound infiltrate persisted ([Fig. 2](#fig2){ref-type="fig"}). Thus, 7 days after the washout at BPEI, the patient was brought back to the operating room for definitive surgical management of the *C. parapsilosis* endophthalmitis. A 23-gauge pars plana vitrectomy was performed, the IOL and the capsular bag were removed *in toto* through a superior 7 mm long scleral tunnel incision 2 mm posterior to the limbus and a 6.5 mm corneal patch graft was performed temporally at the site of the prior cataract wound. The patient was left aphakic and intravitreal voriconazole (0.2 mL of 100 mcg/0.1 mL) and amphotericin B (0.2 mL of 5 mcg/0.1 mL) were injected at the end of the procedure. In view of persistent ocular infection despite prior treatment with intravitreal amphotericin-B, a combination approach was utilized at the time of the definitive surgical procedure. Her post-operative regimen included topical amphotericin B 0.5 mg/mL, voriconazole 1% and cyclosporine 0.5% drops which were slowly tapered ([Fig. 3](#fig3){ref-type="fig"}). Histopathology examination revealed budding yeast along the cornea tunnel ([Fig. 4](#fig4){ref-type="fig"}A) and within the capsular bag ([Fig. 4](#fig4){ref-type="fig"}B). At her 1-year follow up visit her best-corrected vision in that eye is 20/25 with a rigid gas permeable lens and she remains free of recurrence ([Fig. 5](#fig5){ref-type="fig"}).Fig. 2Slit lamp photograph of the patient\'s left eye 6 days after anterior chamber washout, scraping of the endothelial plaque, and two intracameral and intravitreal amphotericin B (5 mg/mL) injections. The stromal infiltrate along the cornea tunnel and the hypopyon persisted.Fig. 2Fig. 3Slit lamp photograph of the patient\'s left eye 1 week after pars plana vitrectomy, removal of the intraocular lens and capsular bag, cornea patch graft and intravitreal voriconazole and amphotericin B injections.Fig. 3Fig. 4Histopathology examination revealed PAS-positive budding yeast in 4A--40x magnification and 400x magnification (in inset) of corneal tissue including clear corneal incision. 4B - 40x magnification and 400x magnification (in inset) of the capsular bag.Fig. 4Fig. 5Slit lamp photograph of the patient\'s left eye 6 months after pars plana vitrectomy, removal of the IOL/capsular bag complex, a corneal patch graft and intravitreal amphotericin B (5 mg/mL) and voriconazole (10 mg/mL) injections. Following removal of all sutures and fitting of a rigid gas permeable lens 1 year post operatively she remains free of recurrence with a best-corrected visual acuity of 20/25 with a rigid gas permeable contact lens.Fig. 5

3. Discussion {#sec3}
=============

Candida endophthalmitis after cataract surgery typically has a delayed-onset presentation, as it is often masked by a favorable response to the frequent steroid use immediately after surgery. Candida species is well known for its tendency to form biofilms and, thus, successful treatment of the infection often requires removal of the IOL/capsular bag complex along with pars plana vitrectomy and intravitreal antifungals.[@bib13]

Fungal corneal tunnel infections after phacoemulsification cataract surgery are rare with only 23 cases having been reported in the literature ([Table 1](#tbl1){ref-type="table"}).[@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29] Twelve eyes (52.2%) progressed to endophthalmitis with poor visual outcomes (visual acuity ≤ 20/400) in 3 patients and loss of the eye in 4 patients (3 became phthisical and one underwent evisceration). In 14 of the 23 cases (60.9%) the main incision was clear corneal and in 9 (39.1%) it was sclerocorneal. The latency period between the date of the cataract surgery and the presentation of the fungal tunnel infection ranged from 3 days to 15 years (median, 30 days). Most infections were caused by *Aspergillus* spp. (n = 12, 52.2%), two by *Fusarium* spp. (8.7%), two by *Alternaria* spp. (8.7%), two by *Candida albicans* (8.7%), one by *Candida parapsilosis* (4.3%), one by *Scedosporium apiospermum* (4.3%) and one by *Phialemonium curvatum* (4.3%). In two (9.1%) of the reported cases the fungal elements were seen on smear, but the organisms did not grow on culture media.Table 1Review of cases, interventions, and outcomes of fungal cornea tunnel infections after cataract surgery via phacoemulsification.Table 1AuthorAge (years)IncisionLatent period (Days)OrganismMethod of Organism IsolationEndophthalmitisInterventionFinal BCVAKitahata et al. (2016)77Sclerocorneal5400Fusarium spp.Culture of aqueous humor and of endothelial plaqueYes[a](#tbl1fna){ref-type="table-fn"}Anterior chamber washout, then sclerocorneal patch graft\
Topical, Intracameral and Intravenous voriconazole\
Topical natamycin20/5076Sclerocorneal360Septate filamentous fungusSmear of corneal wound infiltrate, culture was negativeYes[a](#tbl1fna){ref-type="table-fn"}Medical management, then sclerocorneal patch graft\
Topical and Oral voriconazole\
Topical natamycin\
Intravitreal amphotericin B20/320Khochtali et al. (2016)42Clear Corneal45Alternaria spp.Culture and pathology of corneal biopsyNoTopical and Oral voriconazole20/400Jutley et al. (2015)65Clear Corneal45*Scedosporium apiospermum*Culture of corneal scrapingsNoTopical and Oral voriconazole\
Topical natamycin\
Amniotic membrane transplantation20/150Erdem et al. (2015)80Clear Corneal30*Aspergillus terreus*Culture of corneal scrapingsNoTopical voriconazole\
Topical natamycin20/50Esposito et al. (2014)66Clear Corneal180Alternaria spp.Culture of corneal scrapingsNoTopical and Subconjunctival amphotericin B\
Oral ketoconazole20/63Hilda et al. (2014)55Clear Corneal7*Aspergillus flavus*Culture of corneal scrapingsYes[a](#tbl1fna){ref-type="table-fn"}Medical management, then PPV, removal of IOL/capsular bag, therapeutic PKP\
Topical, Intracameral and Intravitreal voriconazole\
Topical natamycin\
Topical fluconazole\
Oral itraconazoleHand Motion59Clear Corneal7*Aspergillus flavus*Culture of corneal scrapingsYes[a](#tbl1fna){ref-type="table-fn"}Medical management, then PPV, removal of IOL/capsular bag, therapeutic PKP\
Topical, Intracameral and Intravitreal voriconazole\
Topical natamycin\
Oral itraconazoleCounting FingersRoy et al. (2012)75Sclerocorneal15FungusSmear of anterior chamber exudates, culture was negativeYesTissue adhesive\
Anterior chamber washout\
Topical natamycin\
Oral itraconazoleFreda et al. (2011)84Clear Corneal30*Phialemonium curvatum*Culture of corneal scrapingsYes[a](#tbl1fna){ref-type="table-fn"}Medical management, then therapeutic PKP and scleral patch graft\
Intracameral, Intravitreal & Topical amphotericin B\
Topical natamycinEviscerationMittal et al. (2010)44Clear Corneal30*Aspergillus flavus*Culture of corneal scrapingsYes[a](#tbl1fna){ref-type="table-fn"}Medical management, then sclerocorneal patch graft Topical, Intracameral and Oral voriconazole\
Topical natamycin\
Topical amphotericin B20/60Jain et al. (2010)50Clear Corneal30*Aspergillus flavus*Culture of corneal scrapingsNoTopical and Intrastromal voriconazole\
Topical natamycin20/50Araki-Sasaki et al. (2009)74Clear Corneal120*Candida albicans*Culture of endothelial plaque, culture of aqueous humor was negativeNoAnterior chamber washout\
Topical fluconazole\
Topical micafungin\
Oral itraconazole20/100Gregori et al. (2007)78Clear Corneal7*Candida parapsilosis*Culture of aqueous humorYes[a](#tbl1fna){ref-type="table-fn"}Medical management, then PPV, removal of IOL/capsular bag, therapeutic PKP\
Topical and Intravitreal amphotericin B\
Oral ketoconazole20/400Jhanji et al. (2007)69Sclerocorneal37Fusarium spp.Culture of corneal scrapingsNoAnterior chamber washout\
Topical and Intracameral amphotericin B\
Topical and Oral voriconazole\
Topical natamycin20/60Kehdi et al. (2005)79Clear Corneal37Aspergillus spp.Culture of aqueous humor and corneal scrapingsYes[a](#tbl1fna){ref-type="table-fn"}Medical management, then sclerocorneal patch graft\
Topical, Intravitreal and Intravenous amphotericin B\
Topical econazole Intravenous fluconazole\
Oral itraconazole20/60Garg et al. (2003)70Sclerocorneal3*Aspergillus flavus*Culture of corneoscleral biopsy and aqueous humorYes[a](#tbl1fna){ref-type="table-fn"}Medical management, then PPV, removal of IOL/capsular bag, therapeutic PKP\
Topical natamycin\
Oral ketoconazolePhthisis70Clear Corneal9*Aspergillus flavus*Culture of corneoscleral biopsy and aqueous humorYes[b](#tbl1fnb){ref-type="table-fn"}Medical management, then patient refused surgery\
Topical natamycin\
Oral ketoconazolePhthisis68Clear Corneal8*Candida albicans*Culture of corneoscleral biopsy and aqueous humorNoTopical and Oral fluconazole\
Topical amphotericin B20/12574Sclerocorneal3*Aspergillus terreus*Culture of corneal scrapingsNoTopical natamycin\
Oral ketoconazole20/2070Sclerocorneal5Aspergillus spp.Culture of corneal scrapingsYes[b](#tbl1fnb){ref-type="table-fn"}Medical management, then patient refused surgery\
Topical natamycin\
Oral itraconazolePhthisisMendicute et al. (2000)83Sclerocorneal10*Aspergillus fumigatus*Culture of corneal scrapingsNo[a](#tbl1fna){ref-type="table-fn"}Medical management, then sclerocorneal patch graft\
Topical amphotericin B\
Oral itraconazole20/4064Sclerocorneal15*Aspergillus fumigatus*Culture of corneal scrapingsNoTopical amphotericin B\
Oral itraconazole20/35[^1][^2][^3]

The current patient represents the second case reported in the literature of *C. parapsilosis* cornea tunnel infection complicated by endophthalmitis. The first case, reported by Gregori et al., in 2007, also failed medical management with intravitreal amphotericin B and pars plana vitrectomy with removal of the IOL/capsular bag complex and therapeutic penetrating keratoplasty were required.[@bib25] The final visual acuity for that patient was 20/400. The two cases of tunnel infections caused by the related species *C. albicans* did not result in endophthalmitis and were treated with topical and oral antifungals ([Table 1](#tbl1){ref-type="table"}).

In total, in 10 (43.5%) fungal tunnel infections, medical management with topical, intraocular and systemic antifungals failed to control the infection, thus a sclerocorneal patch graft or therapeutic penetrating keratoplasty was performed and it was combined with pars plana vitrectomy in 3 of them. Two patients refused surgery upon failure of medical management of the infection and both of those eyes became phthisical. The mean best-corrected vision for all cases with a fungal tunnel infection was 20/400 and the median was 20/100.

This patient remains free of recurrence 1 year after the combined cornea IOL/capsular bag explantation and retina surgery. Current visual acuity corrects to 20/25 with a rigid gas permeable lens. In this patient, management of combined fungal cornea tunnel infection and endophthalmitis was successful after removal of all possible infectious niches and the long-term outcome was favorable.

4. Conclusions {#sec4}
==============

Fungal tunnel infections after phacoemulsification cataract surgery are not common, yet when they result in fungal late-onset endophthalmitis, management can be challenging. The goal is to eradicate any source of infection within the eye and in the cornea. Medical management alone (with topical, intraocular, and systemic antifungals) often fails to control the infection and a combined surgical approach can be pursued to remove the IOL/capsular bag and to replace the infected corneal stroma with a healthy graft.
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[^1]: PKP, penetrating keratoplasty; IOL, intraocular lens, PPV -- pars plana vitrectomy, BCVA -- best corrected visual acuity.

[^2]: In these cases, topical, intracameral and systemic antifungals ± anterior chamber washout was not curative. Fungal infiltrates recurred along the cornea tunnel. Thus, a tectonic (patch) graft ± pars plana vitrectomy was performed.

[^3]: In these cases, the infection progressed to endophthalmitis despite medical management. Therapeutic penetrating keratoplasty with IOL explantation, pars plana vitrectomy and injection of intravitreal antifungals was advised, but the patients refused. Eventually, these eyes became phthisical.
